Actively Recruiting
Phase 1B Study to Collect Serum After Vaccination with Gamma-PN Pneumococcal Vaccine in Adults for Assay Testing
Led by GPN Vaccines · Updated on 2025-10-03
12
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to collect serum samples from adults vaccinated with Gamma-PN, a killed whole-cell pneumococcal vaccine, to help develop and validate laboratory tests that measure immune response. The study focuses on adults in good general health, aged 18 to 69 years, who have not previously received a pneumococcal vaccine. It is an early phase study designed to gather important data for assay validation. Participants will receive a single intramuscular dose of 500 mcg of Gamma-PN vaccine. Serum samples will be collected before vaccination and again on Day 28 after vaccination. The vaccine administration and sample collection are straightforward, with no placebo or comparison groups involved. During the study, participants will have blood drawn to collect serum at the specified time points. Researchers will monitor immune response by measuring the opsonophagocytic activity OPA at six months. The total study duration includes vaccination, follow-up blood draws, and monitoring to support assay development. Participants can expect a limited number of visits focused on vaccination and blood sample collection.
CONDITIONS
Brief Title
Serum Collection Study for Assay Development
Research Team
N
Nerissa Lakhan, PhD
P
Paul E Rolan, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here